Overview

Global Bare Metal Stents market reached US$ YY million in 2023 and is expected to reach US$ YY million by 2031, growing at a CAGR of YY% during the forecast period 2024-2031.

A bare metal stent is a tube that resembles a mesh created from thin, uncoated metal wire. Bare metal stents are made up of a variety of alloys that include stainless steel, cobalt-chromium alloy, and platinum chromium alloys.

They are made up of a metal stent that is left bare and a polymer mesh sleeve that is attached to the strut's outside surface to trap thrombotic material behind the struts. Bare-metal coronary artery stents are used in percutaneous coronary intervention (PCI) for a variety of indications, including stable and unstable angina, acute myocardial infarction (MI), and multiple-vessel disease.

Market Dynamics: Drivers & Restraints

Increase in the prevalence of coronary heart diseases

The increasing prevalence of coronary heart disease is expected to drive the market growth. There is a growing need for bare metal stents as the number of people with CHD diagnoses rises and increases the prospective patient pool that requires stent implants. To better serve certain CHD situations or patient groups, manufacturers may concentrate on creating new and enhanced bare metal stents. This would increase their market options.

For instance, according to the Centers for Disease Control and Prevention (CDC) in 2021, it is estimated coronary heart disease killed around 375,476 people in 2021 and is estimated that it is the most common type of heart disease. Thus, the above factors are expected to drive market growth in the forecast period.

Complications associated with bare metal stents

Adoption of bare metal stents may be impacted by complications such as restenosis, thrombosis, and bleeding, which can have a detrimental effect on patient outcomes and satisfaction and possibly make patients reluctant to have BMSs implanted. Managing problems raises the total cost of care, placing a strain on healthcare systems and perhaps lowering the cost-effectiveness of BMS in comparison to other available treatments. Thus, the above factors can hinder the market growth.

Segment Analysis

The global bare metal stents market is segmented based on the product type, application, end-user, and region.

Cobalt-chromium Alloy Stents segment is expected to dominate the market share

Cobalt-chromium Alloy Stents segment is expected to hold the leading position in the market share during the forecast period. This is due to the efficiency of the stents over the other types. CoCr stents have a high level of corrosion resistance, which guarantees stent integrity over the long run and may lead to increased longevity. Compared to possibly excessively stiff PtCr stents, CoCr stents can better conform to the geometry of the artery because they strike a good compromise between thinness and flexibility. Compared to thicker struts, thinner struts have a decreased likelihood of restenosis because they provide less surface area for tissue development. Thus, the above factors are expected to hold the segment in the dominant position in the forecast period.

Geographical Analysis

North America is expected to hold a significant position in the bare metal stents market share.

North America has been holding the dominant position in the market share and is expected to continue throughout the forecast period due to the increase in the prevalence of heart disease in the region, the presence of large medical device manufacturing companies and also the strategies developed by the companies in the region.

For instance, according to the Centers for Disease Control and Prevention report in 2022, it is reported that about 4.9% of individuals have been diagnosed with coronary heart disease. About 695,000 people die of heart disease in the United States every year. Every year about 805,000 Americans have a heart attack. Thus, the above factors are expected to hold the region in the dominant position.

COVID-19 Impact Analysis

COVID-19 has impacted the growth of the market negatively. Global supply chains were disturbed by lockdowns and limitations, which affected the supply of completed stents and raw materials. This resulted in price volatility and shortages. To reduce infection risks and provide priority to COVID-19 patients, elective treatments such as stent placements were frequently canceled or postponed.

Market Segmentation

By Product Type:

  • Cobalt-chromium Alloy Stents
  • Stainless Steel Stent
  • Platinum Chromium Alloy Stents

By Application:

  • For Large Vessel (greater than 3mm)
  • For Small Vessel (<3mm)

By End-User:

  • Hospitals
  • Ambulatory Surgical Centers
  • Cardiac Catheterization Laboratories
  • Others

By Region:

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Rest of Europe
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • Rest of Asia-Pacific
  • Middle East and Africa

Competitive Landscape

The major global players in the market include Boston Scientific Corporation, Biotronik, B. Braun Melsungen, Meril Life Sciences Pvt. Ltd., Macromed (UK) Ltd, GENOSS Co., Ltd., SLTL Group and Nano Therapeutics Pvt. Ltd. among others.

Why Purchase the Report?

  • To visualize the global bare metal stents market segmentation based on the product type, application, end-user, and region as well as understand key commercial assets and players.
  • Identify commercial opportunities by analyzing trends and co-development.
  • Excel data sheet with numerous data points of the bare metal stents market level with all segments.
  • PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
  • Product mapping available as excel consisting of key products of all the major players.

Target Audience 2023

  • Manufacturers/ Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies